In people with obesity, women’s fat tissue under the skin has about 60% more of a specific molecule (IRS1) that helps respond to insulin than men’s, and this difference is real—not just due to chance.
See the scientific wording
In obese adults, subcutaneous adipose tissue exhibits 60% higher expression of insulin receptor substrate 1 (IRS1) mRNA in women compared to men, and this difference remains statistically significant after correction for multiple comparisons (p < 0.0001).
Correlational — new studies may shift this
ObservationalOne moderate-quality study links this claim to the outcome, but causation is not established.
What the research says
1 study reviewedSupporting (1)
Cross-Sectional StudyHuman2024
In obese people, women’s fat cells make 60% more of a key insulin-signaling molecule called IRS1 than men’s fat cells, and this difference is real and not due to chance — the study proves it.
Contradicting (0)
No contradicting studies found yet
That doesn't mean it's settled — it just means no study has tested the opposite.
Quality-weighted scoring: we follow the GRADE framework — each study is rated High, Moderate, Low, or Very Low based on study design, methodology rigor, and risk of bias. A single high-quality RCT can outweigh several weaker observational studies.
Scores reflect study quality, not just count.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting study
How Fit Body Science checks a claim
- 1
We isolate the claim
Health advice from videos, articles and studies is broken down into single, testable claims.
- 2
We find the research
Each claim is matched against peer-reviewed studies, with every source cited by DOI.
- 3
We grade the evidence
Studies are scored on methodology, statistical rigor, transparency and publication quality.
The fitness and health internet is full of confident claims. We check them against real research.
Every claim on this site is traced back to peer-reviewed studies, scored on methodology and reporting quality, and given a verdict you can audit yourself — sources, DOIs and all.
- Full evidence breakdown and mechanism chains
- Ask our AI anything about a claim or its studies
- Get notified when new research changes a verdict
In people with obesity, women’s fat tissue under the skin has about 60% more of a specific molecule (IRS1) that helps respond to insulin than men’s, and this difference is real—not just due to chance.
Evidence from Studies
Supporting (1)
Community contributions welcome
Sex differences in adipose insulin resistance are linked to obesity, lipolysis and insulin receptor substrate 1
In obese people, women’s fat cells make 60% more of a key insulin-signaling molecule called IRS1 than men’s fat cells, and this difference is real and not due to chance — the study proves it.
Contradicting (0)
Community contributions welcome
Score Breakdown
No multi-axis breakdown available yet. The overall Pro / Against score above is the best signal.
- No clinical evidence is available; the score reflects mechanistic plausibility only.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Whether the observed difference in IRS1 mRNA levels between obese men and women is reproducible in a well-characterized cohort.
Recruit 200 obese adults (100 men, 100 women) matched for age, BMI, waist circumference, and metabolic health markers. Obtain subcutaneous adipose tissue biopsies via standardized surgical procedure under local anesthesia. Extract RNA and quantify IRS1 mRNA using RT-qPCR with technical replicates and normalization to multiple stable reference genes. Apply Bonferroni or FDR correction for multiple gene comparisons. Analyze group differences using ANCOVA adjusting for covariates (age, BMI, fasting insulin).
Whether IRS1 mRNA levels are consistently elevated in women across different subcutaneous fat depots and independent of confounding factors.
Identify 50 obese women and 50 obese men with no metabolic disease (controls) and 50 obese women and 50 obese men with insulin resistance (cases). Match all groups for age, BMI, and ethnicity. Collect paired subcutaneous (abdominal and thigh) and visceral adipose tissue biopsies. Perform RNA-seq to quantify IRS1 transcript levels. Use multivariate regression to isolate sex as an independent predictor of IRS1 expression after adjusting for fat depot location, insulin sensitivity, and adipocyte size.
Whether the 60% difference is consistent across independent studies and populations.
Systematically search public RNA-seq datasets (e.g., GTEx, GEO) for studies reporting IRS1 mRNA levels in subcutaneous adipose tissue of obese adults stratified by sex. Include only studies with RNA quality metrics, normalized expression values, and clear BMI criteria (>30 kg/m²). Pool standardized mean differences using random-effects models. Assess heterogeneity and publication bias. Perform subgroup analysis by ethnicity and menopausal status.
Whether the sex difference in IRS1 expression is stable over time or changes with weight loss or hormonal shifts.
Follow 100 obese men and 100 obese women for 2 years. Collect subcutaneous adipose tissue biopsies at baseline, 12 months, and 24 months. Measure IRS1 mRNA alongside sex hormones (estradiol, testosterone), insulin sensitivity (HOMA-IR), and adipocyte size. Use mixed-effects models to assess whether sex predicts IRS1 expression trajectory independently of weight change.
Whether sex differences in IRS1 expression are intrinsic to adipocytes or driven by systemic factors.
Isolate primary subcutaneous adipocytes from 20 obese men and 20 obese women (matched for BMI and age). Culture cells under identical conditions for 72 hours. Measure IRS1 mRNA levels via RT-qPCR. Treat subsets with physiological concentrations of estradiol and testosterone to test hormonal modulation. Compare baseline and hormone-treated expression between sexes using two-way ANOVA.